MedTrace Logo

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

NCT00964821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 459

Last updated 2017-11-07

No results posted yet for this study

Summary

RATIONALE: Studying immune response to flu vaccine in patients who have undergone a stem cell transplant may help doctors plan the best treatment.

PURPOSE: This clinical trial is studying flu vaccine to see how well it works in preventing infection in patients who have undergone a stem cell transplant and in healthy volunteers.

Conditions

Interventions

BIOLOGICAL

trivalent influenza vaccine

Patients or normal volunteers who will be vaccinated against the flu.

OTHER

Immunoenzyme technique

This test will determine the level of antibodies in participants who have been vaccinated against the flu and those who have not been vaccinated against the flu.

OTHER

Laboratory biomarker analysis

This test will count the number of T cells (the cells that kill the flu virus) in participants who have been vaccinated against the flu and those who have not been vaccinated against the flu.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Don Diamond, PhD · City of Hope Medical Center

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00964821 on ClinicalTrials.gov